Who
Adrian Gottschalk
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Foghorn Therapeutics.
In numbers
- Trades disclosed
- 38
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 27 Oct 2020
- Last trade
- 10 Apr 2026
- Last filed
- 13 Apr 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Apr 2026filed 13 Apr 2026 | FHTX Foghorn TherapeuticsBiotechnology | SEC FORM 4 Code G | —59,208 at $0.00 | filing |
| 10 Apr 2026filed 13 Apr 2026 | FHTX Foghorn TherapeuticsBiotechnology | SEC FORM 4 Code G | —59,208 at $0.00 | filing |
| 10 Apr 2026filed 13 Apr 2026 | FHTX Foghorn TherapeuticsBiotechnology | SEC FORM 4 Code G | —59,208 at $0.00 | filing |
| 10 Apr 2026filed 13 Apr 2026 | FHTX Foghorn TherapeuticsBiotechnology | SEC FORM 4 Code G | —59,208 at $0.00 | filing |
| 9 Apr 2026filed 13 Apr 2026 | FHTX Foghorn TherapeuticsBiotechnology | SEC FORM 4 Code G | —47,497 at $0.00 | filing |
| 9 Apr 2026filed 13 Apr 2026 | FHTX Foghorn TherapeuticsBiotechnology | SEC FORM 4 Code G | —47,497 at $0.00 | filing |
| 9 Apr 2026filed 13 Apr 2026 | FHTX Foghorn TherapeuticsBiotechnology | SEC FORM 4 Code G | —47,497 at $0.00 | filing |
| 9 Apr 2026filed 13 Apr 2026 | FHTX Foghorn TherapeuticsBiotechnology | SEC FORM 4 Code G | —47,497 at $0.00 | filing |
| 5 Feb 2026filed 6 Feb 2026 | FHTX Foghorn Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | $5.6M1,075,000 at $5.23 | filing |
| 5 Feb 2026filed 6 Feb 2026 | FHTX Foghorn Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | $5.6M1,075,000 at $5.23 | filing |
| 25 Apr 2025filed 28 Apr 2025 | FHTX Foghorn TherapeuticsBiotechnology | SEC FORM 4 Code G | —300,000 at $0.00 | filing |
| 25 Apr 2025filed 28 Apr 2025 | FHTX Foghorn TherapeuticsBiotechnology | SEC FORM 4 Code G | —300,000 at $0.00 | filing |
| 9 Apr 2025filed 10 Apr 2025 | FHTX Foghorn TherapeuticsBiotechnology | SEC FORM 4 Code G | —197,906 at $0.00 | filing |
| 9 Apr 2025filed 10 Apr 2025 | FHTX Foghorn TherapeuticsBiotechnology | SEC FORM 4 Code G | —197,906 at $0.00 | filing |
| 22 Jan 2025filed 24 Jan 2025 | FHTX Foghorn Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | $1.7M400,000 at $4.37 | filing |
| 24 Jan 2024filed 25 Jan 2024 | FHTX Foghorn Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | $918K300,000 at $3.06 | filing |
| 17 Aug 2023filed 18 Aug 2023 | FHTX Foghorn TherapeuticsBiotechnology | SEC FORM 4 Code G | —63,000 at $0.00 | filing |
| 17 Aug 2023filed 18 Aug 2023 | FHTX Foghorn TherapeuticsBiotechnology | SEC FORM 4 Code G | —63,000 at $0.00 | filing |
| 26 May 2023filed 31 May 2023 | FHTX Foghorn TherapeuticsBiotechnology | SEC FORM 4 Code G | —300,000 at $0.00 | filing |
| 26 May 2023filed 31 May 2023 | FHTX Foghorn TherapeuticsBiotechnology | SEC FORM 4 Code G | —300,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.